D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 46 Citations 7,440 157 World Ranking 15251 National Ranking 644

Overview

What is he best known for?

The fields of study he is best known for:

  • DNA
  • Gene
  • Enzyme

His scientific interests lie mostly in Oligonucleotide, Molecular biology, Biochemistry, Aptamer and DNA. His research on Oligonucleotide also deals with topics like

  • Gene expression together with Sense,
  • Translation that connect with fields like Globin. The study incorporates disciplines such as Recombinant DNA, Messenger RNA, Reticulocyte, Transcription and Ribosome in addition to Molecular biology.

His work on Nuclease, Phosphodiester bond and Antisense oligonucleotides as part of general Biochemistry study is frequently connected to Conjugate, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Aptamer research integrates issues from RNA, Systematic evolution of ligands by exponential enrichment and Surface plasmon resonance. The various areas that Jean-Jacques Toulmé examines in his DNA study include Nucleic acid and RNase H.

His most cited work include:

  • Specific regulation of gene expression by antisense, sense and antigene nucleic acids. (712 citations)
  • Improved leishmanicidal effect of phosphorotioate antisense oligonucleotides by LDL-mediated delivery (224 citations)
  • Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides (210 citations)

What are the main themes of his work throughout his whole career to date?

Jean-Jacques Toulmé mainly focuses on Oligonucleotide, RNA, Aptamer, Molecular biology and Biochemistry. His Oligonucleotide research is under the purview of DNA. His work carried out in the field of DNA brings together such families of science as Polynucleotide, Nucleic acid, Nucleotide and Sense.

His work deals with themes such as Base pair, Transcription and Cell biology, which intersect with RNA. His studies in Aptamer integrate themes in fields like Biophysics, Computational biology, Combinatorial chemistry, Surface plasmon resonance and Systematic evolution of ligands by exponential enrichment. His Molecular biology study integrates concerns from other disciplines, such as Complementary DNA, Messenger RNA and Reverse transcriptase, RNase H.

He most often published in these fields:

  • Oligonucleotide (54.60%)
  • RNA (51.72%)
  • Aptamer (51.15%)

What were the highlights of his more recent work (between 2010-2021)?

  • Aptamer (51.15%)
  • Systematic evolution of ligands by exponential enrichment (27.01%)
  • Oligonucleotide (54.60%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Aptamer, Systematic evolution of ligands by exponential enrichment, Oligonucleotide, RNA and Computational biology. The Aptamer study combines topics in areas such as Biochemistry, Nucleic acid, Ligand, Biophysics and Combinatorial chemistry. He usually deals with Nucleic acid and limits it to topics linked to DNA and Phosphodiester bond.

In the subject of general Systematic evolution of ligands by exponential enrichment, his work in SELEX Aptamer Technique is often linked to Selection, thereby combining diverse domains of study. His Oligonucleotide study typically links adjacent topics like Biosensor. His RNA research includes themes of Base pair and Surface plasmon resonance.

Between 2010 and 2021, his most popular works were:

  • Riboswitches based on kissing complexes for the detection of small ligands. (37 citations)
  • 99mTc-MAG3-Aptamer for Imaging Human Tumors Associated with High Level of Matrix Metalloprotease-9 (34 citations)
  • Nucleic acids targeted to drugs: SELEX against a quadruplex ligand (31 citations)

In his most recent research, the most cited papers focused on:

  • DNA
  • Gene
  • Enzyme

Jean-Jacques Toulmé mostly deals with Aptamer, Systematic evolution of ligands by exponential enrichment, Surface plasmon resonance, RNA and Biophysics. His research brings together the fields of Biochemistry and Aptamer. His studies in Biochemistry integrate themes in fields like Molecular biology and Fluorescence anisotropy.

His Systematic evolution of ligands by exponential enrichment research integrates issues from Oligonucleotide, DNA, Nucleic acid and Small molecule. His biological study spans a wide range of topics, including G-quadruplex and Binding site. His RNA study frequently draws connections to other fields, such as Nucleotide.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Specific regulation of gene expression by antisense, sense and antigene nucleic acids.

Claude Hélène;Jean-Jacques Toulmé.
Biochimica et Biophysica Acta (1990)

1161 Citations

Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides

C. Cazenave;C.A. Stein;N. Loreau;N.T. Thuong.
Nucleic Acids Research (1989)

331 Citations

Enzymatic amplification of translation inhibition of rabbit β-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents

Christian Cazenave;Nadine Loreau;Nguyen T. Thuong;Jean-Jacques Toulmé.
Nucleic Acids Research (1987)

234 Citations

Improved leishmanicidal effect of phosphorotioate antisense oligonucleotides by LDL-mediated delivery

Rakesh Kumar Mishra;Catherine Moreau;Claude Ramazeilles;Serge Moreau.
Biochimica et Biophysica Acta (1995)

227 Citations

In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1.

Frédéric Ducongé;Jean-Jacques Toulmé.
RNA (1999)

188 Citations

Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism

Claudine Boiziau;Robin Kurfurst;Christian Cazenave;Victoria Roig.
Nucleic Acids Research (1991)

179 Citations

DNA Aptamers Selected Against the HIV-1trans-Activation-responsive RNA Element Form RNA-DNA Kissing Complexes

Claudine Boiziau;Eric Dausse;Ludmila Yurchenko;Jean-Jacques Toulmé.
Journal of Biological Chemistry (1999)

174 Citations

Antimessenger oligodeoxyribonucleotides: an alternative to antisense RNA for artificial regulation of gene expression--a review.

J.-J. Toulmé;C. Hélène.
Gene (1988)

163 Citations

DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.

Marie-Line Andreola;Frédéric Pileur;Christina Calmels;Michel Ventura.
Biochemistry (2001)

160 Citations

New candidates for true antisense.

Jean-Jacques Toulmé;Jean-Jacques Toulmé.
Nature Biotechnology (2001)

139 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jean-Jacques Toulmé

Claude Hélène

Claude Hélène

Grenoble Alpes University

Publications: 49

Muthiah Manoharan

Muthiah Manoharan

Alnylam Pharmaceuticals (United States)

Publications: 34

Eric E. Swayze

Eric E. Swayze

Ionis Pharmaceuticals (United States)

Publications: 31

Phillip Dan Cook

Phillip Dan Cook

Ionis Pharmaceuticals (United States)

Publications: 31

Antonin de Fougerolles

Antonin de Fougerolles

Alnylam Pharmaceuticals (United States)

Publications: 28

Stanley T. Crooke

Stanley T. Crooke

Ionis Pharmaceuticals (United States)

Publications: 25

Patrick L. Iversen

Patrick L. Iversen

Oregon State University

Publications: 24

C. Frank Bennett

C. Frank Bennett

Ionis Pharmaceuticals (United States)

Publications: 24

Jesper Wengel

Jesper Wengel

University of Southern Denmark

Publications: 23

Punit P. Seth

Punit P. Seth

Ionis Pharmaceuticals (United States)

Publications: 23

Peter E. Nielsen

Peter E. Nielsen

University of Copenhagen

Publications: 23

Ivan Huc

Ivan Huc

Ludwig-Maximilians-Universität München

Publications: 18

Piet Herdewijn

Piet Herdewijn

KU Leuven

Publications: 17

Yi Lu

Yi Lu

University of Illinois at Urbana-Champaign

Publications: 16

Michel Monsigny

Michel Monsigny

University of Orléans

Publications: 15

Nicholas M. Dean

Nicholas M. Dean

Ionis Pharmaceuticals (United States)

Publications: 15

Trending Scientists

Gregor Schöner

Gregor Schöner

Ruhr University Bochum

Simon Brendle

Simon Brendle

Columbia University

Davit Zargarian

Davit Zargarian

University of Montreal

Alexander Vainstein

Alexander Vainstein

Hebrew University of Jerusalem

Paul C. Driscoll

Paul C. Driscoll

University College London

Michael Bate

Michael Bate

University of Cambridge

L. Michael Romero

L. Michael Romero

Tufts University

Eduardo Salido

Eduardo Salido

Hospital Universitario de Canarias

Akhilesh C. Mishra

Akhilesh C. Mishra

National Institute of Virology

Kang-Kun Lee

Kang-Kun Lee

Seoul National University

Mariachiara Chiantore

Mariachiara Chiantore

University of Genoa

Tomo'omi Kumagai

Tomo'omi Kumagai

University of Tokyo

Stewart A. Anderson

Stewart A. Anderson

Children's Hospital of Philadelphia

Wendy M. Rodgers

Wendy M. Rodgers

University of Alberta

Bernardo L. Horta

Bernardo L. Horta

Universidade Federal de Pelotas

Ladislav Valach

Ladislav Valach

University of Zurich

Something went wrong. Please try again later.